tiprankstipranks
Paradigm Biopharmaceuticals Ltd. (PBIGF)
OTHER OTC:PBIGF
Holding PBIGF?
Track your performance easily

Paradigm Biopharmaceuticals Ltd. (PBIGF) Financial Statements

12 Followers

Paradigm Biopharmaceuticals Ltd. Financial Overview

Paradigm Biopharmaceuticals Ltd.'s market cap is currently ―. The company's EPS TTM is $-0.124; its P/E ratio is -1.71; Paradigm Biopharmaceuticals Ltd. is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 39.67MAU$ 71.03MAU$ 103.92MAU$ 78.84MAU$ 2.45M
Total AssetsAU$ 50.69MAU$ 84.79MAU$ 112.36MAU$ 85.51MAU$ 15.19M
Total DebtAU$ 616.67KAU$ 751.84KAU$ 873.69KAU$ 0.00AU$ 0.00
Net DebtAU$ -39.06MAU$ -70.28MAU$ -103.05MAU$ -78.84MAU$ -2.45M
Total LiabilitiesAU$ 8.38MAU$ 6.52MAU$ 4.18MAU$ 2.70MAU$ 1.33M
Stockholders EquityAU$ 42.31MAU$ 78.27MAU$ 108.18MAU$ 82.81MAU$ 13.86M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Paradigm Biopharmaceuticals Ltd. Earnings and Revenue History

Paradigm Biopharmaceuticals Ltd. Debt to Assets

Paradigm Biopharmaceuticals Ltd. Cash Flow

Paradigm Biopharmaceuticals Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis